NYU Dentistry awarded NIH grant to investigate oral cancer pain treatment utilizing co-delivery of DNA and RNA

(New York University) NYU College of Dentistry clinician-scientists Seiichi Yamano and Brian Schmidt have set out to develop a new class of medicines using gene therapy to effectively and safely treat oral cancer pain. The National Institute of Dental and Craniofacial Research (NIDCR), part of the National Institutes of Health (NIH), has awarded the researchers a five-year, $3,276,000 grant to test whether nonviral co-delivery of DNA and RNA will safely alleviate oral cancer pain.